Market Overview:
The global invertase market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth of the market can be attributed to the increasing demand for invertase from food and beverage, pharmaceuticals, personal care, and other applications. In addition, the growing awareness about the benefits of invertase is also contributing to the growth of this market.
Product Definition:
Invertase is an enzyme that catalyzes the hydrolysis of sucrose to glucose and fructose. It is important in the production of high-fructose corn syrup, as well as in digestion.
Plant:
The global invertase market size was valued at USD 8.5 million in 2015 and is expected to grow at a CAGR of XX% over the forecast period on account of increasing demand from various end-use industries including food & beverages, pharmaceuticals, chemicals, oilseeds processing and others.
Microorganisms:
Microorganisms are living organisms, which are generally smaller than bacteria and can be used in various applications. Microorganisms include fungi, protozoa & viruses. Fungi is the most common microorganism found in nature that helps plants to absorb nutrients from soil and also protect them from pathogens (diseases causing agents). Some of the other microorganisms include algae, bacteria & yeast among others.
Application Insights:
The food and beverages segment dominated the global invertase market, accounting for a revenue share of over 40.0% in 2017. The growth can be attributed to the extensive usage of invertase enzymes as an active ingredient in soft drinks, juices, energy drinks and various other fruit-based beverages on a commercial scale. In addition, growing demand for carbonated soft drinks (CSD) is expected to augment industry growth over the forecast period due to increasing consumption worldwide.
In terms of revenue, pharmaceuticals are anticipated to witness significant growth during the forecast period owing to rising geriatric population across countries such as India and China coupled with high incidence of diseases such as diabetes mellitus around the world.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position through the forecast period on account of high product demand from various end-use industries, such as food & beverages, pharmaceuticals, and personal care. In addition, rising awareness regarding health benefits associated with invertase products is anticipated to propel regional growth over the next eight years.
Europe accounted for a significant share of revenue in 2017 owing to growing consumer preference toward natural and healthy products across major countries including Germany, France, Italy Spain U.K., and Russia among others.
Growth Factors:
- Increasing demand for bakery and confectionery products owing to changing lifestyle and growing disposable income of consumers.
- Rising awareness about the health benefits of Invertase among consumers, especially in developed countries.
- Technological advancements in the production of Invertase that has resulted in improved quality and efficiency.
Scope Of The Report
Report Attributes
Report Details
Report Title
Invertase Market Research Report
By Type
Plant, Microorganisms
By Application
Food & Beverages, Pharmaceuticals, Personal Care, Others
By Companies
Koninklijke DSM N.V., Parchem Fine & Specialty Chemicals, SternEnzym GmbH & Co. KG, Kerry Inc., Meteoric Exim Private Limited, MP Biomedicals, LLC., BIO-CAT, Megazyme Inc
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global Invertase Market Report Segments:
The global Invertase market is segmented on the basis of:
Types
Plant, Microorganisms
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Food & Beverages, Pharmaceuticals, Personal Care, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Koninklijke DSM N.V.
- Parchem Fine & Specialty Chemicals
- SternEnzym GmbH & Co. KG
- Kerry Inc.
- Meteoric Exim Private Limited
- MP Biomedicals, LLC.
- BIO-CAT
- Megazyme Inc
Highlights of The Invertase Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Plant
- Microorganisms
- By Application:
- Food & Beverages
- Pharmaceuticals
- Personal Care
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Invertase Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Invertase is an enzyme that catalyzes the chemical reaction of glucose to fructose in the body. Invertase helps to break down complex carbohydrates into their simpler forms, which can be used by the body for energy.
Some of the major players in the invertase market are Koninklijke DSM N.V., Parchem Fine & Specialty Chemicals, SternEnzym GmbH & Co. KG, Kerry Inc., Meteoric Exim Private Limited, MP Biomedicals, LLC., BIO-CAT, Megazyme Inc.
The invertase market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Invertase Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Invertase Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Invertase Market - Supply Chain
4.5. Global Invertase Market Forecast
4.5.1. Invertase Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Invertase Market Size (000 Units) and Y-o-Y Growth
4.5.3. Invertase Market Absolute $ Opportunity
5. Global Invertase Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Invertase Market Size and Volume Forecast by Type
5.3.1. Plant
5.3.2. Microorganisms
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Invertase Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Invertase Market Size and Volume Forecast by Application
6.3.1. Food & Beverages
6.3.2. Pharmaceuticals
6.3.3. Personal Care
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Invertase Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Invertase Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Invertase Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Invertase Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Invertase Demand Share Forecast, 2019-2026
9. North America Invertase Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Invertase Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Invertase Market Size and Volume Forecast by Application
9.4.1. Food & Beverages
9.4.2. Pharmaceuticals
9.4.3. Personal Care
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Invertase Market Size and Volume Forecast by Type
9.7.1. Plant
9.7.2. Microorganisms
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Invertase Demand Share Forecast, 2019-2026
10. Latin America Invertase Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Invertase Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Invertase Market Size and Volume Forecast by Application
10.4.1. Food & Beverages
10.4.2. Pharmaceuticals
10.4.3. Personal Care
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Invertase Market Size and Volume Forecast by Type
10.7.1. Plant
10.7.2. Microorganisms
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Invertase Demand Share Forecast, 2019-2026
11. Europe Invertase Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Invertase Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Invertase Market Size and Volume Forecast by Application
11.4.1. Food & Beverages
11.4.2. Pharmaceuticals
11.4.3. Personal Care
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Invertase Market Size and Volume Forecast by Type
11.7.1. Plant
11.7.2. Microorganisms
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Invertase Demand Share, 2019-2026
12. Asia Pacific Invertase Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Invertase Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Invertase Market Size and Volume Forecast by Application
12.4.1. Food & Beverages
12.4.2. Pharmaceuticals
12.4.3. Personal Care
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Invertase Market Size and Volume Forecast by Type
12.7.1. Plant
12.7.2. Microorganisms
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Invertase Demand Share, 2019-2026
13. Middle East & Africa Invertase Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Invertase Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Invertase Market Size and Volume Forecast by Application
13.4.1. Food & Beverages
13.4.2. Pharmaceuticals
13.4.3. Personal Care
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Invertase Market Size and Volume Forecast by Type
13.7.1. Plant
13.7.2. Microorganisms
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Invertase Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Invertase Market: Market Share Analysis
14.2. Invertase Distributors and Customers
14.3. Invertase Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Koninklijke DSM N.V.
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Parchem Fine & Specialty Chemicals
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. SternEnzym GmbH & Co. KG
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Kerry Inc.
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Meteoric Exim Private Limited
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. MP Biomedicals, LLC.
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. BIO-CAT
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Megazyme Inc
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook